Pilot Study demonstrates Vapotherm HVNI technology is more effective than standard oxygen therapy for treatment of acute asthma in children

Vapotherm, Inc. , a global medical technology company focused on the development and commercialization of its proprietary Vapotherm high velocity therapy® products, which are used to treat patients...

Related Keywords

United Kingdom ,United States ,Mexico ,Brighton ,Brighton And Hove ,New Hampshire ,Sussex ,East Sussex ,Exeter ,Devon ,America ,Hector Rojas Anaya ,Paul Seddon ,Drug Administration ,European Respiratory Society International Congress ,Joe Army ,Exchange Commission ,Sussex Clinical Trial Unit At University Hospitals ,Emergency Department ,Allergy Foundation Of America ,Vapotherm Inc ,Sussex Clinical Trial Unit ,University Hospitals ,Jessica Whittle ,Chief Medical Officer ,Allergy Foundation ,Precision Flow ,Investor Relations ,Private Securities Litigation Reform Act ,High Velocity Therapy ,Annual Report ,Quarterly Report ,Markets ,